MRNA · Company research
Moderna, Inc. (MRNA): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 196.48 | $78,517,440,000 | 76794440000.00 | 11.1829025844930417 | — | — | 541.4995862068965517 | 11.6132879751516048 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.